Hampshire Hospitals NHS Foundation Trust - Basingstoke and North Hampshire Hospital

The Hampshire Hospitals NHS Foundation Trust - Basingstoke and North Hampshire Hospital incorporates Basingstoke and North Hampshire Hospital https://www.hampshirehospitals.nhs.uk/
Case Ascertainment for 2018-19 and 2019-20 was calculated for the entire trust. Inaccuracies in the data for circumferential resection margins have been noted for this Trust for patients diagnosed 2019-20.

View Trust Services

This trust offers the following services:

  • Surgical services:
    • On-site hepatobiliary surgical team
  • Advanced disease services:
    • Dedicated Specialist Advanced Nurse
    • Dedicated Specialist Advanced MDT
    • Dedicated Specialist Advanced Outpatient Clinic
    • HIPEC/cytoreductive surgery
  • Diagnostic and pre-operative services:
    • Routine Genetic Testing for Lynch Syndrome
  • Support service facilities:
    • Dedicated nurses for ERAS services
    • Availability of 24 hour palliative care advice
    • 7-day access to face-to-face palliative care services

Data Quality
All Patients: Trust Network National
Number of patients in Audit 183 1833 35779
Case ascertainment (%) Fair Good Good
Data completeness of:
– Pre-treatment TNM (%) 96 91 86
– Performance status (%) 91 75 89
Patients having major resection: Trust Network National
Number of patients in Audit 95 1075 19631
ASA grade 1 (%) 4 4 9
ASA grade 2 (%) 56 56 53
ASA grade 3 (%) 39 28 31
ASA grade 4+ (%) 1 2 2
ASA grade not recorded (%) N/A 11 4
Data completeness of:
7 Audit items for risk-adjustment (%) 92 78 87

Key:

> 80%
50 - 80%
< 50%

Management of all patients
All Patients: Trust Network National
Number of patients in Audit 183 1833 35779
Seen by Clinical Nurse Specialist (%) 95 76 88

Management of patients having major resection
Patients having major resection: Trust Network National
Number of patients in Audit 95 1075 19614
Distant metastases (%) 3 5 5
Urgent or emergency surgery (%) 6 10 15
At least 12 lymph nodes excised (%) 88 75 84
Laparoscopic surgery attempted (%) 92 75 72
Risk-adjusted length of stay > 5 days (%) 55 51 55
Patients having major resection for stage III colon cancer: Trust Network National
Number of patients in audit 44 N/A 10747
Adjuvant chemotherapy (%) 59 N/A 62
Patients receiving chemotherapy after major resection for stage III colon cancer: Trust Network National
Number of patients in audit 25 N/A 6608
Severe acute toxicity after adjuvant chemotherapy (%) 25 N/A 22

Rectal cancer patients
Patients having major resection: Trust Network National
Number of patients in Audit 19 N/A 4251
Neoadjuvant therapy (%) 5 N/A 33
Circumferential resection margin: Recorded (%) 89 79 89
Circumferential resection margin: Negative (%) 84 74 83
Rectal volume 20 N/A 4377
Patients in APER/Hartmanns estimate: Trust Network National
Number of patients in APER/Hartmanns estimate 101 978 19644
APER/Hartmanns (%) 15 26 37

Compare trust outcomes

Copyright © 2024 National Bowel Cancer Audit | Lovingly Crafted by Mixd